ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1163

Dynamic Regulation of Enhancers and Super-Enhancers in Rheumatoid Arthritis Synovial Finroblasts

Sung-Ho Park1, Christopher Sohn1, Konstantinos Loupasakis2, Angela Lee3, Eugenia Giannopoulou1, Lionel B. Ivashkiv3 and George D. Kalliolias1, 1Hospital for Special Surgery, New York, NY, 2Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, New York, NY, 3Medicine, Hospital for Special Surgery, New York, NY

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Epigenetics, fibroblasts and rheumatoid arthritis, Gene Expression, GWAS, pathogenesis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Enhancers are regulatory elements that modulate transcriptional rates of genes. Super-enhancers (SupE) are extremely large enhancers associated primarily with highly expressed genes that have critical functions in health and disease. The purpose of this study was to map typical enhancers and super-enhancers (SupE) in rheumatoid arthritis (RA) synovial fibroblasts (FLS).

Methods: Chromatin immunoprecipitation sequencing (ChIPseq) was used to evaluate H3K27 acetylation (Ac) genome-wide in control and TNF-stimulated FLS. Typical enhancers and SupE, were identified by H3K27Ac signal, using HOMER in a similar manner to the method described in Whyte et al. Cell 2013;153(2):307-19.

Results: The number and distribution of typical enhancers and SupE in FLS is modulated by TNF-stimulation in a time-dependent manner (Figure 1A-B). In some loci TNF-stimulation induces SupE (Figure 1C-D) and in others, baseline SupE are down-regulated or abrogated (Figure 1E). SupE-associated genes display significantly higher expression levels, compared to typical-enhancer-associated genes, in control and TNF-stimulated cells (Figure 2A). 16 RA-associated Single Nucleotide Polymorphisms (SNPs) are localized within SupE in RA FLS (Figure 2B).   

Conclusion: The enhanceosome and super-enhanceosome is highly dynamic in RA FLS. TNFa has a genome-wide impact on FLS chromatin, suggesting that during the course of synovitis inflammatory mediators induce a pathogenic behavior by altering the landscape of enhancers and SupE in FLS. RA-associated SNPs are enriched in SupE of RA FLS, supporting the critical role of FLS in RA pathogenesis.   

Figure 1.jpg

Figure 2.jpg


Disclosure: S. H. Park, None; C. Sohn, None; K. Loupasakis, None; A. Lee, None; E. Giannopoulou, None; L. B. Ivashkiv, None; G. D. Kalliolias, None.

To cite this abstract in AMA style:

Park SH, Sohn C, Loupasakis K, Lee A, Giannopoulou E, Ivashkiv LB, Kalliolias GD. Dynamic Regulation of Enhancers and Super-Enhancers in Rheumatoid Arthritis Synovial Finroblasts [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/dynamic-regulation-of-enhancers-and-super-enhancers-in-rheumatoid-arthritis-synovial-finroblasts/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dynamic-regulation-of-enhancers-and-super-enhancers-in-rheumatoid-arthritis-synovial-finroblasts/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology